Capital expenditure · 2011–2025
TG Therapeutics capital expenditure
$214,000+375.6% · FY2025
TG Therapeutics (TGTX) reported $214,000 in capital expenditure for fiscal 2025, +375.6% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $214,000 | +375.6% | Open → |
| FY20242024-12-31 | $45,000 | +$45,000 | Open → |
| FY20232023-12-31 | $0 | −100.0% | Open → |
| FY20222022-12-31 | $14,000 | −96.5% | Open → |
| FY20212021-12-31 | $401,000 | +12.3% | Open → |
| FY20202020-12-31 | $357,000 | +172.5% | Open → |
| FY20192019-12-31 | $131,000 | +45.6% | Open → |
| FY20182018-12-31 | $90,000 | +4,400.0% | Open → |
| FY20172017-12-31 | $2,000 | −99.4% | Open → |
| FY20162016-12-31 | $344,000 | +714.8% | Open → |
| FY20152015-12-31 | $42,217 | +127.3% | Open → |
| FY20142014-12-31 | $18,570 | +226.9% | Open → |
| FY20132013-12-31 | $5,681 | +306.1% | Open → |
| FY20122012-12-31 | $1,399 | +$1,399 | Open → |
| FY20112011-12-31 | $0 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=TG Therapeutics capital expenditure |url=https://companiesranked.com/en/company/tg-therapeutics/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). TG Therapeutics capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/tg-therapeutics/capital-expenditureBibTeX
@misc{companiesranked-en-company-tg-therapeutics-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{TG Therapeutics capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/tg-therapeutics/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001437749-26-006133 · February 27, 2026
{{cite web |title=TG Therapeutics capital expenditure — 10-K (0001437749-26-006133) |url=https://www.sec.gov/Archives/edgar/data/1001316/000143774926006133/tgtx20251231_10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.